动脉粥样硬化性肾动脉狭窄介入治疗与药物治疗的临床观察

Clinical Observation of Interventional Therapy and Drug Therapy for Atherosclerotic Renal Artery

目的分析动脉粥样硬化性肾动脉狭窄介入治疗与药物治疗的临床效果。方法研究对象为我院随机选取的100例动脉粥样硬化性肾动脉狭窄患者,研究时间为2015年7月~2016年8月,研究对象分类为对照组、观察组,每组纳入50例患者。在治疗方法层面,对照组行常规介入治疗,观察组在介入治疗基础上联合药物进行治疗,总结归纳两组患者的治疗效果。结果在各类治疗指标层面,观察组治疗效果明显趋近于理想状态,与对照组相比,治疗有效率、治疗满意度、肾功能指标均更接近预设值,P〈0.05,差异有统计学意义。结论采用介入联合药物治疗动脉粥样硬化性肾动脉狭窄能够较好缓解患者的临床症状,改善患者肾功能,提高生活质量,进而维护患者健康,应用价值较高。

Objective To analyze the clinical effect of interventional therapy and drug therapy for atherosclerotic renal artery stenosis. MethodsA total of 100 patients with atherosclerotic renal artery stenosis were randomly selected from our hospital from July 2015 to August 2016. The subjects were divided into control group and observation group. 50 patients patient in each group. At the level of the treatment, the control group received routine interventional therapy. The observation group was treated with the combination therapy on the basis of the interventional therapy. The therapeutic effect of the two groups was summarized. ResultsCompared with the control group, the treatment efficiency, treatment satisfaction and renal function index were all closer to the preset values than those of the control group, P〈0.05. There were statistically significant differences between the treatment group and the control group Significance. Conclusion The treatment of atherosclerotic renal artery stenosis with interventional drugs can relieve the clinical symptoms, improve the renal function and improve the quality of life of the patient, thus maintaining the health of patients, the application value is higher.